Advertisement

Mercado de Polymarket

Prediction market

Track current outcome prices, market depth, volume, liquidity, and recent trades for Prediction market.

Proximo
Probabilidad
12.5%
Liquidez
$40.26K
Mejor compra
0.1%
Mejor venta
99.9%
Spread
99.8%
Ultimo trade
12.5%

Outcomes

Resultados del mercado

Yes 12.5% Current quote
No 12.5% Current quote

Precio en vivo

Precio y liquidez

Compra, venta, punto medio, spread y profundidad actuales para este resultado.

Mejor compra
0.1%
Mejor venta
99.9%
Punto medio
50%
Spread
99.8%
Ultimo trade
12.5%
Profundidad
1777,24 / 38.485,09

Historial de precios

Esperando historial de precios

Historial no disponible

Compras

PrecioTamano
0.1%195
0.2%25
1.3%550
1.4%50
1.6%312.5
1.9%16
2%294
4.8%334.74

Ventas

PrecioTamano
99.9%180,16
99.8%25
99.7%28.900
99.6%14,12
98%1800
97.9%29,25
90%51
86.1%1500

Trades

Trades recientes

Latest visible trades for this market.

  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?
    Yes 12.5% 35.44 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?
    No 81.1% 200 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?
    Yes 4.2% 24 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?
    Yes 4.7% 413 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?
    Yes 3% 545.67 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?
    Yes 3.8% 13 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?
    Yes 3.8% 13.31 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?
    Yes 1.4% 13.31 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?
    Yes 1.7% 100 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?
    No 87.4% 50 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?
    No 95.3% 412.64 shares
  • Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?
    No 98% 134.8 shares
Advertisement
Advertisement